But the “enhancement” industry is still hobbled by out-of-date regulation

Two of the first patients of adaptive Deep Brain Sitimulation (aDBS) Parkinson’s therapy and the neurologist who developed the care system share how life changes and how it doesn’t when receiving the groundbreaking new FDA-approved treatment mitigating the most disruptive symptoms of the progressive neurological disease, which still has no cure.

Until now, skin cells have been viewed as barriers that can respond to electric stimuli. Turns out, they also generate electric spikes, similar to neurons.

Thankfully, there are ways to mitigate risk.

This ‘deceptively simple’ question demands a dip into the murky waters of quantum physics.

We have an opportunity to build systems that don’t just replicate our current inequities. Will we take them?

Antibiotics increase the gut oxygen levels and favor growth of harmful fungi. Chemically restoring intestinal gut hypoxia could deter fungal blooms.

A real bit of cyborg hardware highlights the technology’s current limitations.

A study of James Webb Space Telescope images finds astronomers should factor the Milky Way’s rotational velocity in observations of deep space galaxies.

Biotech incubator Flagship Pioneering has uncorked its latest company. Lila Sciences is looking to use $200 million in seed funding to develop new advanced artificial intelligence that can power fully autonomous research labs, according to a March 10 press release.

In addition to Flagship, the financing comes from General Catalyst, March Capital, the ARK Venture Fund, Altitude Life Science Ventures, Blue Horizon Advisors, the State of Michigan Retirement System, Modi Ventures and a wholly owned subsidiary of the Abu Dhabi Investment Authority, according to the release.